India to inspect drug firms for EU, WHO compliance

03/20/2013 | Economic Times (India), The

India's Drug Controller General plans to begin inspections of drug companies exporting to Europe to ensure that they are meeting requirements set by the World Health Organization for the manufacture of active pharmaceutical ingredients. Once a firm is found compliant with WHO regulations, it will receive a three-year certificate of good manufacturing practices. India exports more than $13 billion in pharmaceutical products annually, of which APIs account for about 40%.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC